ArticleScientific reports2019

Increasing plasma ADAMTS13 activity is associated with HBeAg seroconversion in chronic hepatitis B patients during 5 years of entecavir treatment.

Renyong Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.